Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

67.32
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
25.92
Today|||52-Week Range
67.41
+14.72%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close67.32
Today’s open65.94
Day’s range65.68 - 67.41
Volume95,165
Average volume (3 months)170,555
Market cap$1.3B
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-19.47%
Earnings growth (this year)-259.80%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.48%
P/E ratio74.0
Price/Sales8.83
Price/Book4.18

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...0.000.00%
SPPISpectrum Pharmaceuti...0.000.00%
EGRXEagle Pharmaceutical...0.000.00%
ITCIIntra-Cellular Thera...0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$0.13
Annual revenue (last year)$102.8M
Annual profit (last year)$17.7M
Net profit margin17.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
CFO, Principal Accounting Officer &
SVP-Finance
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts